Literature DB >> 28507455

Neoadjuvant chemoradiotherapy of the rectal carcinoma - The correlation between the findings on the restaging multiparametric 3T MRI scanning and the surgical findings.

Radovan Vojtíšek1, Eva Korčáková2, Jan Mařan1, Ondřej Šorejs1, Jindřich Fínek1.   

Abstract

AIM: To figure out how to correlate the findings on functional MRI and carried out after neoadjuvant CRT of rectal carcinoma with final histology after surgery.
BACKGROUND: Neoadjuvant CRT is the standard treatment of locally advanced rectal carcinoma. Its use leads to the downstaging of the disease and in 15-42% of patients even to the detection of pCR after TME. The use of functional MRI improves the sensitivity and specificity of pCR detection up to 52-64% and 89-98%, respectively.
MATERIALS AND METHODS: Between January 2013 and June 2016, 67 patients suffering from histologically proven locally advanced rectal cancer underwent neoadjuvant RT or CRT. We selected for further investigation only patients (33 patients) who underwent pelvic staging and restaging using multiparametric imaging on 3T MRI scanner. We compared the findings on functional MRI after neoadjuvant CRT with final histology after surgery.
RESULTS: In 15 patients pathologic staging of primary tumor differed from expected staging assessed according to preoperative MRI. In 5 patients pathologic complete remission was achieved. In none of these 5 patients pCR was predicted using preoperative MRI. Sensitivity and specificity of MRI in predicting pCR were 0% and 96%. Accuracy of MRI in predicting pT and pN was 79% and 74%.
CONCLUSIONS: We have verified that the use of neoadjuvant CRT in the treatment of locally advanced rectal carcinoma leads to a possible achievement of pCR. But in our group of patients this was not predictable nor was it with the use of multiparametric 3T MRI.

Entities:  

Keywords:  3T MRI scanning; Neoadjuvant chemoradiotherapy; Rectal carcinoma; Restaging

Year:  2017        PMID: 28507455      PMCID: PMC5422007          DOI: 10.1016/j.rpor.2017.02.004

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  38 in total

1.  Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis.

Authors:  Eisar Al-Sukhni; Laurent Milot; Mark Fruitman; Joseph Beyene; J Charles Victor; Selina Schmocker; Gina Brown; Robin McLeod; Erin Kennedy
Journal:  Ann Surg Oncol       Date:  2012-01-20       Impact factor: 5.344

2.  Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy.

Authors:  Angelita Habr-Gama; Rodrigo O Perez; Igor Proscurshim; Fábio G Campos; Wladimir Nadalin; Desiderio Kiss; Joaquim Gama-Rodrigues
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

3.  Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer.

Authors:  Joon Seok Lim; Daehong Kim; Song-Ee Baek; Sungmin Myoung; Junjeong Choi; Sang Joon Shin; Myeong-Jin Kim; Nam Kyu Kim; Jinsuk Suh; Ki Whang Kim; Ki Chang Keum
Journal:  Eur Radiol       Date:  2012-03-17       Impact factor: 5.315

4.  Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer.

Authors:  M J Gollub; D H Gultekin; O Akin; R K Do; J L Fuqua; M Gonen; D Kuk; M Weiser; L Saltz; D Schrag; K Goodman; P Paty; J Guillem; G M Nash; L Temple; J Shia; L H Schwartz
Journal:  Eur Radiol       Date:  2011-11-20       Impact factor: 5.315

5.  Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization.

Authors:  Angelita Habr-Gama; Rodrigo O Perez; Gregory Wynn; John Marks; Hermann Kessler; Joaquim Gama-Rodrigues
Journal:  Dis Colon Rectum       Date:  2010-12       Impact factor: 4.585

6.  Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

Authors:  Rolf Sauer; Torsten Liersch; Susanne Merkel; Rainer Fietkau; Werner Hohenberger; Clemens Hess; Heinz Becker; Hans-Rudolf Raab; Marie-Therese Villanueva; Helmut Witzigmann; Christian Wittekind; Tim Beissbarth; Claus Rödel
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

7.  Role of three-dimensional anorectal ultrasonography in the assessment of rectal cancer after neoadjuvant radiochemotherapy: preliminary results.

Authors:  Sthela M Murad-Regadas; Francisco Sergio P Regadas; Lusmar V Rodrigues; Rosilma G L Barreto; Francisco Coracy C Monteiro; Beethoven B Landim; Erico C Holanda
Journal:  Surg Endosc       Date:  2008-09-24       Impact factor: 4.584

8.  Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer.

Authors:  Matthew F Kalady; Luiz Felipe de Campos-Lobato; Luca Stocchi; Daniel P Geisler; David Dietz; Ian C Lavery; Victor W Fazio
Journal:  Ann Surg       Date:  2009-10       Impact factor: 12.969

9.  Impact of interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer on surgical and oncologic outcome.

Authors:  Wei-Gen Zeng; Zhi-Xiang Zhou; Jian-Wei Liang; Zheng Wang; Hui-Rong Hou; Hai-Tao Zhou; Xing-Mao Zhang; Jun-Jie Hu
Journal:  J Surg Oncol       Date:  2014-05-29       Impact factor: 3.454

10.  Dynamic contrast-enhanced MRI to evaluate the therapeutic response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer.

Authors:  Seung Ho Kim; Jeong Min Lee; Sandeep N Gupta; Joon Koo Han; Byung Ihn Choi
Journal:  J Magn Reson Imaging       Date:  2013-11-04       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.